Avanos Medical (AVNS) stock surged 70% after agreeing to a $1.27 billion all-cash acquisition by American Industrial Partners. Shareholders will receive $25 per share, a 72% premium. The deal, expected to close in the second half of 2026, will take Avanos private and delist it from the NYSE.